Christopher J Ryerson

Summary

Affiliation: University of California
Country: USA

Publications

  1. doi Management of dyspnea in interstitial lung disease
    Christopher J Ryerson
    Department of Medicine, School of Medicine, University of California San Francisco, San Francisco, California, USA
    Curr Opin Support Palliat Care 4:69-75. 2010
  2. doi Depression is a common and chronic comorbidity in patients with interstitial lung disease
    Christopher J Ryerson
    Department of Medicine, School of Medicine, University of California San Francisco, San Francisco, California, USA
    Respirology 17:525-32. 2012
  3. doi Cough predicts prognosis in idiopathic pulmonary fibrosis
    Christopher J Ryerson
    Department of Medicine, University of California San Francisco, San Francisco, California 94143, USA
    Respirology 16:969-75. 2011
  4. doi Depression and functional status are strongly associated with dyspnea in interstitial lung disease
    Christopher J Ryerson
    Department of Medicine, School of Medicine, University of California San Francisco, 505 Parnassus Ave, Box 0111, San Francisco, CA 94143, USA
    Chest 139:609-16. 2011
  5. doi A multidimensional index and staging system for idiopathic pulmonary fibrosis
    Brett Ley
    Department of Medicine, University of California, San Francisco, 505 Parnassus Avenue, Box 0111, San Francisco, CA 94143, USA
    Ann Intern Med 156:684-91. 2012
  6. pmc Cleaved cytokeratin-18 is a mechanistically informative biomarker in idiopathic pulmonary fibrosis
    Seung Ick Cha
    Department of Medicine, University of California, San Francisco School of Medicine, San Francisco, CA 94143 0111, USA
    Respir Res 13:105. 2012
  7. doi Dyspnea in idiopathic pulmonary fibrosis: a systematic review
    Christopher J Ryerson
    Department of Medicine, School of Medicine, University of California at San Francisco, San Francisco, CA, USA
    J Pain Symptom Manage 43:771-82. 2012
  8. ncbi Predictors of mortality in rheumatoid arthritis-related interstitial lung disease
    Deborah Assayag
    Department of Medicine, University of California San Francisco, San Francisco, California, USA
    Respirology 19:493-500. 2014
  9. pmc Prevalence and clinical significance of circulating autoantibodies in idiopathic pulmonary fibrosis
    Joyce S Lee
    Department of Medicine at University of California, San Francisco, 505 Parnassus Avenue, Box 0111, San Francisco, CA 94143, USA
    Respir Med 107:249-55. 2013
  10. doi Update on the diagnosis and classification of ILD
    Christopher J Ryerson
    Department of Medicine, University of British Columbia, Vancouver, Canada
    Curr Opin Pulm Med 19:453-9. 2013

Detail Information

Publications11

  1. doi Management of dyspnea in interstitial lung disease
    Christopher J Ryerson
    Department of Medicine, School of Medicine, University of California San Francisco, San Francisco, California, USA
    Curr Opin Support Palliat Care 4:69-75. 2010
    ..Dyspnea is the most common symptom in interstitial lung disease, yet little is known about its management. This review summarizes the available evidence for the treatment of dyspnea in interstitial lung disease...
  2. doi Depression is a common and chronic comorbidity in patients with interstitial lung disease
    Christopher J Ryerson
    Department of Medicine, School of Medicine, University of California San Francisco, San Francisco, California, USA
    Respirology 17:525-32. 2012
    ..The aim of this study was to determine the prevalence of depression, characterize the association of depression with clinical variables and describe the natural history of depression in patients with ILD...
  3. doi Cough predicts prognosis in idiopathic pulmonary fibrosis
    Christopher J Ryerson
    Department of Medicine, University of California San Francisco, San Francisco, California 94143, USA
    Respirology 16:969-75. 2011
    ..The clinical associations and prognostic value of cough in IPF have not been adequately described. The objective of this study was to describe the characteristics and prognostic value of cough in IPF...
  4. doi Depression and functional status are strongly associated with dyspnea in interstitial lung disease
    Christopher J Ryerson
    Department of Medicine, School of Medicine, University of California San Francisco, 505 Parnassus Ave, Box 0111, San Francisco, CA 94143, USA
    Chest 139:609-16. 2011
    ..The aim of this study was to determine the relationship of dyspnea with clinical parameters, including depression and functional status, in patients with ILD...
  5. doi A multidimensional index and staging system for idiopathic pulmonary fibrosis
    Brett Ley
    Department of Medicine, University of California, San Francisco, 505 Parnassus Avenue, Box 0111, San Francisco, CA 94143, USA
    Ann Intern Med 156:684-91. 2012
    ..Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease with an overall poor prognosis. A simple-to-use staging system for IPF may improve prognostication, help guide management, and facilitate research...
  6. pmc Cleaved cytokeratin-18 is a mechanistically informative biomarker in idiopathic pulmonary fibrosis
    Seung Ick Cha
    Department of Medicine, University of California, San Francisco School of Medicine, San Francisco, CA 94143 0111, USA
    Respir Res 13:105. 2012
    ....
  7. doi Dyspnea in idiopathic pulmonary fibrosis: a systematic review
    Christopher J Ryerson
    Department of Medicine, School of Medicine, University of California at San Francisco, San Francisco, CA, USA
    J Pain Symptom Manage 43:771-82. 2012
    ..Little is known about the treatment and correlates of dyspnea in idiopathic pulmonary fibrosis (IPF)...
  8. ncbi Predictors of mortality in rheumatoid arthritis-related interstitial lung disease
    Deborah Assayag
    Department of Medicine, University of California San Francisco, San Francisco, California, USA
    Respirology 19:493-500. 2014
    ..Mortality in RA-ILD is associated with several patient- and ILD-specific variables; however, previous studies are of low quality. ..
  9. pmc Prevalence and clinical significance of circulating autoantibodies in idiopathic pulmonary fibrosis
    Joyce S Lee
    Department of Medicine at University of California, San Francisco, 505 Parnassus Avenue, Box 0111, San Francisco, CA 94143, USA
    Respir Med 107:249-55. 2013
    ..The objective of this study was to determine the frequency and clinical significance of circulating autoantibodies in idiopathic pulmonary fibrosis...
  10. doi Update on the diagnosis and classification of ILD
    Christopher J Ryerson
    Department of Medicine, University of British Columbia, Vancouver, Canada
    Curr Opin Pulm Med 19:453-9. 2013
    ..In addition, the strengths and limitations of the current approach to ILD diagnosis and management are discussed...
  11. doi Hemodynamic stability after intraarterial injection of verapamil for cerebral vasospasm
    Alana M Flexman
    Department of Anesthesia and Perioperative Care, University of California San Francisco, San Francisco, CA, USA
    Anesth Analg 114:1292-6. 2012
    ....